India, Aug. 11 -- Vivos Therapeutics Inc. (VVOS), a medical device and healthcare services company focused on obstructive sleep apnea and other sleep-related breathing disorders, has announced an expanded strategic partnership with Greenway Health.
Under the expanded partnership, Vivos will deploy Greenway Health's AI-enabled Novare platform across its growing clinical operations.
The implementation has already begun at Sleep Centers of Nevada (SCN), where Greenway estimates that Novare and related workflow automation could generate approximately $9.1 million in annual value creation, including increased patient capacity and revenue-cycle improvements.
Vivos also estimates potential annual savings of up to $1.8 million at SCN from the re...